Aspirin or coumadin are for clots, (Antithrombotic and Thrombolytic Therapy), the American College of Chest Physicians (ACCP) recommended coumadin for atrial fibrillation patients at high
risk of stroke, aspirin for patients at low
risk of stroke, and either drug
of patients with an intermediate risk. The ACCP defines a low-risk patient as younger than 65 years with no predisposing risk factors (e.g., previous stroke, TIA, embolism, heart failure, hypertension, diabetes).